Dr Martens has reported a bounce in income and raised its steerage for income development subsequent 12 months as the enduring boots model shrugs off inflation and the consequences of the pandemic.
The firm, which listed in London final 12 months, mentioned it bought extra boots than ever in 2021 and expects income to develop within the “high teens” within the subsequent monetary 12 months. Sales grew 18 per cent to £908.3mn within the 12 months to the top of March, whereas pre-tax revenue almost quadrupled to £214.3mn.
Shares within the firm jumped 25.5 per cent in early morning buying and selling on Tuesday to 271.6p. The firm floated at 370p a share.
Taking again management over gross sales, by ending contracts with distributors that provide Dr Martens to wholesalers, has been one among chief government Kenny Wilson’s principal aims when he set out 4 years in the past to rejuvenate the model as soon as revered by punks and skinheads.
He credited the transfer for the gross sales rise. “It was really powered by direct-to-consumer — our own stores and websites,” he mentioned, including that promoting on to shoppers boosted margins and that the branded shops function advertising and marketing, driving on-line spending.
“When we open a retail store in a specific city, it drives performance on the website,” he mentioned, citing examples of retailer openings in Texas having boosted native buying on its web site by as much as 80 per cent.
Dr Martens mentioned it plans to open between 25 and 35 new shops within the subsequent 12 months, primarily within the US and Europe together with Italy and Germany. In Japan, the corporate has begun a push to finish franchise contracts and take again possession of Dr Martens-branded shops.
Wilson mentioned shoppers in Germany and the US had up to now 12 months been shopping for extra Dr Martens merchandise per head, a pattern that he was assured can be repeated in different international locations. “That’s why we’re feeling confident . . . there’s vast untapped potential of the business,” he mentioned.
Analysts at Investec mentioned Dr Martens’ previous monetary 12 months had been “executed beautifully” and was a testomony to the “power of its proven . . . strategy”.
Inflation pushed the retailer’s value base up by 6 per cent up to now 12 months, however the firm mentioned this may be offset by value will increase deliberate from July.
Wilson remained assured of the model’s future development. “Our brand positioning has always been about rebellious self-expression, being an individual — and everyone wants to be an individual,” he mentioned.
Private fairness group Permira, which in 2013 purchased a struggling Dr Martens for £300mn, made greater than a tenfold return on its funding when Dr Martens final 12 months hit a £3.7bn valuation at its preliminary public providing.